Schizophrenia
📧 Sign up to get email alerts when something new happens for Schizophrenia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2011-05-19Clinical Trial Update: Study on the Safety of Risperidone on Obese or Overweight Patients With Schizophrenia
A terminated clinical trial evaluated the safety of risperidone in obese or overweight patients with schizophrenia or schizoaffective disord…
-
CLINICAL_TRIALS trial_result · 2011-05-18Clinical Trial Update: A Study of How Long it Takes a Patient to Relapse After Switching From an Oral Antipsychotic to One of Two Doses of Long-acting Risperidone Injections in Patients With Schizophrenia or Schizoaffective Disorder [Phase 3]
This clinical trial update reports the completion of a Phase 3 study assessing how long it takes patients to relapse after switching from an…
-
CLINICAL_TRIALS trial_result · 2011-05-18Clinical Trial Update: A Study of the Long-term Safety and Tolerability and the Long-term Effectiveness of Extended-release Oral Paliperidone in Patients Diagnosed With Schizophrenia [Phase 3]
A Phase 3 study evaluating the long-term safety, tolerability, and effectiveness of extended-release paliperidone in people with schizophren…
-
CLINICAL_TRIALS trial_result · 2011-05-18Clinical Trial Update: Evaluation of Effectiveness and Safety of Paliperidone ER (Extended-release) Compared With Quetiapine in Patients With Schizophrenia [Phase 3]
A Phase 3 trial comparing paliperidone ER with quetiapine in schizophrenia has been completed to evaluate their effectiveness and safety.
-
CLINICAL_TRIALS trial_result · 2011-05-18Clinical Trial Update: A Study of the Effect of Carbamazepine on the Pharmacokinetics of Paliperidone Extended Release (ER) in Patients With Schizophrenia or Bipolar I Disorder [Phase 1]
Phase 1 study evaluating how carbamazepine affects the pharmacokinetics of paliperidone extended-release in people with schizophrenia or bip…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2011-05-18Clinical Trial Update: A Study of the Dose Proportionality of Extended Release Paliperidone [Phase 1]
Phase 1 trial evaluating dose proportionality of extended-release paliperidone in schizophrenia; the study has completed.
-
CLINICAL_TRIALS trial_result · 2011-05-18Clinical Trial Update: A Study of QT and QTc Intervals in Patients Administered Extended Release Paliperidone or Quetiapine [Phase 1]
A Phase 1 study update assessing the effects of extended-release paliperidone and quetiapine on QT and QTc intervals in patients with schizo…
-
CLINICAL_TRIALS trial_result · 2011-05-18Clinical Trial Update: Evaluation of the Usefulness to Doctors of the Risperdal Consta Treatment Guidebook Over a Three-month Period During Which Adult Patients With Schizophrenia or Schizoaffective Disorder Are Switching From Daily Doses or Risperidone Tablets to Long-acting Risperidone by Injection [Phase 3]
A Phase 3 study evaluated how useful a Risperdal Consta treatment guidebook is for doctors when adults with schizophrenia or schizoaffective…
-
CLINICAL_TRIALS trial_result · 2011-05-18Clinical Trial Update: A Study of the Bioequivalence of 12 mg Paliperidone Extended Release Tablets Manufactured at Gurabo and Vacaville [Phase 1]
Phase 1 bioequivalence study comparing 12 mg paliperidone extended-release tablets manufactured at two sites (Gurabo and Vacaville) in schiz…
-
CLINICAL_TRIALS trial_result · 2011-05-18Clinical Trial Update: A Study of the Effect of Food and Posture on the Pharmacokinetics of a Single Dose of ER OROS Paliperidone [Phase 1]
Phase 1 study assessing how food and posture influence the pharmacokinetics of a single dose of extended-release paliperidone (ER OROS) in s…
-
CLINICAL_TRIALS trial_result · 2011-05-18Clinical Trial Update: Injection Site Tolerability of Multiple Dose Treatment With Long-acting Injectable Risperidone Administered Via Deltoid Muscle in Chronic Schizophrenia Patients. [Phase 3]
Phase 3 clinical trial evaluating injection-site tolerability of multiple-dose long-acting injectable risperidone administered via the delto…
-
CLINICAL_TRIALS trial_result · 2011-05-17Clinical Trial Update: An Exploratory Study on the Safety and Effectiveness of Paliperidone in Patients With Schizophrenia [Phase 2]
A Phase 2 exploratory study evaluating the safety and effectiveness of paliperidone in patients with schizophrenia has been completed.
-
CLINICAL_TRIALS trial_result · 2011-05-17Clinical Trial Update: A Study of the Efficacy and Safety of Long-acting Injectable Risperidone and Risperidone Tablets in Patients With Schizophrenia [Phase 3]
Phase 3 trial evaluating the efficacy and safety of long-acting injectable risperidone and oral risperidone tablets in schizophrenia has com…
-
CLINICAL_TRIALS trial_result · 2011-05-17Clinical Trial Update: Evaluation of the Efficacy and Safety of Risperidone Injections Given Once a Month to Adults With Schizophrenia or Schizoaffective Disorder [Phase 3]
A Phase 3 clinical trial evaluated monthly injections of risperidone for efficacy and safety in adults with schizophrenia or schizoaffective…
-
CLINICAL_TRIALS trial_result · 2011-05-17Clinical Trial Update: A Long-term Safety Study for Long-acting Injectable Risperidone in Schizophrenia or Schizoaffective Disorder Patients. [Phase 3]
Phase 3 long-term safety study of long-acting injectable risperidone in schizophrenia or schizoaffective disorder patients has completed.
-
CLINICAL_TRIALS trial_result · 2011-05-17Clinical Trial Update: A Long Term Study of Safety for Long Acting Injectable Risperidone in Patients With Schizophrenia or Schizoaffective Disorder. [Phase 3]
Update on long-term safety results from a Phase 3 study of a long-acting injectable risperidone in adults with schizophrenia or schizoaffect…
-
CLINICAL_TRIALS trial_result · 2011-05-17Clinical Trial Update: A Study of the Effects of Risperidone and Olanzapine on Blood Glucose (Sugar) in Patients With Schizophrenia or Schizoaffective Disorder [Phase 4]
Phase 4 trial assessing the effects of risperidone and olanzapine on blood glucose in patients with schizophrenia or schizoaffective disorde…
-
CLINICAL_TRIALS trial_result · 2011-05-17Clinical Trial Update: A Pharmacokinetic and Safety Study of Risperidone Long Acting Injectable in Schizophrenic Patients [Phase 1, Phase 2]
This clinical trial update covers pharmacokinetic and safety data for risperidone long-acting injectable in schizophrenia patients in Phase …
-
CLINICAL_TRIALS trial_result · 2011-05-17Clinical Trial Update: Treatment With Risperidone Long Acting Injectable (RLAI) in an Early Phase of Psychosis [Phase 4]
This document reports the completion of a Phase 4 trial evaluating risperidone long-acting injectable in early psychosis.
-
CLINICAL_TRIALS trial_result · 2011-05-17Clinical Trial Update: A 2-year Study of Patients With Schizophrenia Who Are Treated With Long-acting Injectable Risperidone. [Phase 4]
This document reports the completion of a 2-year Phase 4 clinical trial evaluating outcomes in schizophrenia patients treated with long-acti…
-
CLINICAL_TRIALS trial_result · 2011-05-06Clinical Trial Update: A Study to Test the Safety and Tolerability of a New Medication in the Treatment of Schizophrenia [Phase 2]
Phase 2 trial evaluating the safety and tolerability of a new schizophrenia medication was completed, and results were posted in 2011.
-
CLINICAL_TRIALS trial_result · 2011-05-02Clinical Trial Update: Study of Amantadine for Weight Stabilization During Olanzapine Treatment [Phase 1]
A Phase 1 study evaluating whether amantadine can stabilize weight during olanzapine treatment has been completed.
-
CLINICAL_TRIALS trial_result · 2011-05-02Clinical Trial Update: Add On Treatment for Cognitive Deficits in Schizophrenia [Phase 1]
Phase 1 trial evaluating an add-on treatment for cognitive deficits in schizophrenia has completed.
-
CLINICAL_TRIALS trial_result · 2011-04-27Clinical Trial Update: An Evaluation of the Safety and Efficacy of ABT-925 in Subjects With Acute Exacerbation of Schizophrenia [Phase 2]
A Phase 2 trial evaluating ABT-925 for acute exacerbation of schizophrenia was terminated.
-
CLINICAL_TRIALS trial_result · 2011-04-22Clinical Trial Update: Neuromodulation in Depressed and Schizophrenic Patients - Changing MEP (Muscle Evoked Potentials) by tDCS (Transcranial Direct Current Stimulation)
A completed clinical study from Ludwig-Maximilians-Universität Munich investigates transcranial direct current stimulation (tDCS) and its ef…